Therapeutic effect of traditional Chinese medicine on coagulation disorder and accompanying intractable jaundice in hepatitis B virus-related liver cirrhosis patients

Table 2 Balance test for indexes of coagulation function before treatment (mean ± SD)

		Fib (g/L)	PT (s)	PLT (109/L)
Fib (1.6-2.0 g/L) level	Research group	1.68 ± 0.18	20.52 ± 3.12	69.07 ± 32.57
	Control group	1.72 ± 0.15	21.01 ± 3.31	83.60 ± 56.41
	P value	0.279	0.563	0.227
Fib (1.1-1.5 g/L) level	Research group	1.25 ± 0.13	22.27 ± 2.18	59.87 ± 29.90
	Control group	1.29 ± 0.11	22.60 ± 5.75	71.67 ± 24.24
	P value	0.138	0.765	0.099
Fib ( ≤ 1.0 g/L) level	Research group	0.77 ± 0.19	26.59 ± 5.39	62.80 ± 33.19
	Control group	0.79 ± 0.18	31.49 ± 8.68	73.27 ± 57.34
	P value	0.861	0.127	0.608

Anyone in the three subgroups divided by the standard Fib level and the indexes of coagulation function was balanced between research and control groups before treatment.